Brainsway Ltd.

9.37+0.0600+0.64%Vol 16.51K1Y Perf 16.31%
Apr 9th, 2021 15:59 DELAYED
BID9.36 ASK9.43
Open9.31 Previous Close9.31
Pre-Market- After-Market-
 - -  - -%
Target Price
13.88 
Analyst Rating
Strong Buy 1.33
Potential %
48.13 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     55.39
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     55.16
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap104.24M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
69.75 
Earnings Date
24th Mar 2021

Today's Price Range

9.259.50

52W Range

5.5211.04

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.00%
1 Month
9.59%
3 Months
15.68%
6 Months
58.81%
1 Year
16.31%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BWAY9.370.06000.64
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
3.60
3.60
-
0.02
-15.10
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
77.10
-35.00
-21.80
-35.70
-10.85
RevenueValueIndustryS&P 500US Markets
17.90M
1.08
-
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.05-0.0260.00
Q03 2020-0.06-0.0433.33
Q02 2020-0.12-0.0375.00
Q01 2020-0.16-0.156.25
Q04 2019-0.12-0.1016.67
Q03 2019-0.13-0.127.69
Q02 2019-0.11-0.17-54.55
Q01 2019-0.13-0.1115.38
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.0925.00Positive
6/2021 QR-0.0633.33Positive
12/2021 FY-0.247.69Positive
12/2022 FY-0.13-44.44Negative
Next Report Date-
Estimated EPS Next Report-0.05
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume16.51K
Shares Outstanding11.13M
Trades Count339
Dollar Volume1.70M
Avg. Volume79.58K
Avg. Weekly Volume40.62K
Avg. Monthly Volume44.50K
Avg. Quarterly Volume83.38K

Brainsway Ltd. (NASDAQ: BWAY) stock closed at 9.37 per share at the end of the most recent trading day (a 0.64% change compared to the prior day closing price) with a volume of 16.52K shares and market capitalization of 104.24M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 107 people. Brainsway Ltd. CEO is Christopher Richard von Jako.

The one-year performance of Brainsway Ltd. stock is 16.31%, while year-to-date (YTD) performance is 24.27%. BWAY stock has a five-year performance of %. Its 52-week range is between 5.52 and 11.04, which gives BWAY stock a 52-week price range ratio of 69.75%

Brainsway Ltd. currently has a PE ratio of -18.80, a price-to-book (PB) ratio of 7.30, a price-to-sale (PS) ratio of 8.67, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -14.80%, a ROC of -31.60% and a ROE of -24.56%. The company’s profit margin is -10.85%, its EBITDA margin is -21.80%, and its revenue ttm is $17.90 Million , which makes it $1.08 revenue per share.

Of the last four earnings reports from Brainsway Ltd., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. Brainsway Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Brainsway Ltd. is Strong Buy (1.33), with a target price of $13.88, which is +48.13% compared to the current price. The earnings rating for Brainsway Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Brainsway Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Brainsway Ltd. has a Buy technical analysis rating based on Technical Indicators (ADX : 18.02, ATR14 : 0.59, CCI20 : -114.09, Chaikin Money Flow : 0.26, MACD : 0.00, Money Flow Index : 19.87, ROC : -16.25, RSI : 46.63, STOCH (14,3) : 11.43, STOCH RSI : 0.19, UO : 46.94, Williams %R : -88.57), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Brainsway Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
3 (75.00 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.25

Brainsway Ltd.

Brainsway Ltd is an Israel based company engaged in the business of developing and providing advanced technology solutions for the treatment of a variety of brain disorders. Its flagship technology is based on Deep Transcranial Magnetic Stimulation (TMS) which is used for brain disorder treatment such as treatment of depression in patients. The group earns revenues from the sale and lease of devices. It has a business presence in Israel and other foreign countries.

CEO: Christopher Richard von Jako

Telephone: +972 25813140

Address: 19 Hartum Street, Jerusalem 9777518, , IL

Number of employees: 107

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

58%42%

Bearish Bullish

77%23%

News

Stocktwits